Rectal examination in volume determination of carcinoma of the prostate: clinical and anatomical correlations.

Is deleting the digital rectal examination a good idea? West J Med (1991) 1.38

Screening for prostate cancer. West J Med (1995) 1.12

Prediction of pathological tumor volume in clinically localized prostate cancer: value of endorectal coil magnetic resonance imaging. MAGMA (1997) 0.76

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med (1987) 6.41

Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol (1968) 5.98

Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol (1989) 3.78

Antibacterial nature of prostatic fluid. Nature (1968) 3.68

Recurrent urinary infections in adult women. The role of introital enterobacteria. Calif Med (1971) 3.32

Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol (1988) 3.20

Studies of introital colonization in women with recurrent urinary infections. VII. The role of bacterial adherence. J Urol (1977) 3.20

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. J Urol (1989) 3.07

Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer (1993) 2.99

Biological determinants of cancer progression in men with prostate cancer. JAMA (1999) 2.88

Classification of benign diseases associated with prostatic pain: prostatitis or prostatodynia? J Urol (1978) 2.74

Resistance to nalidixic acid. A misconception due to underdosage. JAMA (1976) 2.31

Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. Am J Pathol (2001) 2.21

Diffusion of antibiotics from plasma into prostatic fluid. Nature (1968) 2.18

Origin and evolution of benign prostatic enlargement. Invest Urol (1978) 2.11

The zonal anatomy of the prostate. Prostate (1981) 2.09

Endoscopic suspension of the vesical neck for urinary incontinence. Surg Gynecol Obstet (1973) 2.06

Ultrasound guided transrectal core biopsies of the palpably abnormal prostate. J Urol (1989) 2.06

Serum versus urinary antimicrobial concentrations in cure of urinary-tract infections. N Engl J Med (1974) 2.05

Intraductal dysplasia: a premalignant lesion of the prostate. Hum Pathol (1986) 2.01

Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia. J Urol (2001) 1.87

Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. Cancer Res (1994) 1.85

Patterns of progression in prostate cancer. Lancet (1986) 1.78

The role of vaginal colonization with enterobacteriaceae in recurrent urinary infections. J Urol (1975) 1.77

The histology of interstitial cystitis. Am J Surg Pathol (1990) 1.75

The periurethral glands do not significantly influence the serum prostate specific antigen concentration. J Urol (1996) 1.73

Chronic bacterial prostatitis and the diffusion of drugs into prostatic fluid. J Urol (1970) 1.69

Determination of prostate volume by transrectal ultrasound. J Urol (1991) 1.69

Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study. J Clin Oncol (1985) 1.65

Prostatitis. J R Soc Med (1981) 1.64

Prostate secretory granules in normal and neoplastic prostate glands: a diagnostic aid to needle biopsy. Hum Pathol (2000) 1.63

Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume. Cancer (1993) 1.62

Comparison of mid-lobe versus lateral systematic sextant biopsies in the detection of prostate cancer. Urol Int (1997) 1.60

Primary thyroidlike carcinoma of the kidney. Urology (1996) 1.58

Origin and development of carcinoma in the prostate. Cancer (1969) 1.56

The pathological features and prognosis of prostate cancer detectable with current diagnostic tests. J Urol (1994) 1.53

Transrectal ultrasound appearance of prostatic granulomas secondary to bacillus Calmette-Guerin instillation. J Urol (1997) 1.49

Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer. J Urol (2001) 1.49

Regional morphology and pathology of the prostate. Am J Clin Pathol (1968) 1.46

Endoscopic suspension of the vesical neck for urinary incontinence in females. Report on 203 consecutive patients. Ann Surg (1980) 1.45

Prophylactic efficacy of nitrofurantoin macrocrystals and trimethoprim-sulfamethoxazole in urinary infections. Biologic effects on the vaginal and rectal flora. N Engl J Med (1977) 1.44

The diffusion and concentration of trimethoprim in human vaginal fluid. J Infect Dis (1975) 1.44

Assessment of morphometric measurements of prostate carcinoma volume. Cancer (2000) 1.42

The role of perineural space invasion in the local spread of prostatic adenocarcinoma. J Urol (1989) 1.40

The central role of prostate specific antigen in diagnosis and progression of prostate cancer. J Urol (1995) 1.40

Interstitial cystitis: early diagnosis, pathology, and treatment. Urology (1978) 1.40

Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate. Cancer (1990) 1.40

Comparison of prostate size in university and Veterans Affairs Health Care System patients with negative prostate biopsies. Urology (1998) 1.39

Effect of flutamide and flutamide plus castration on prostate size in patients with previously untreated prostate cancer. Urology (1996) 1.38

Diffusion of sulfonamides from plasma into prostatic fluid. J Urol (1970) 1.38

Reduced 1alpha-hydroxylase activity in human prostate cancer cells correlates with decreased susceptibility to 25-hydroxyvitamin D3-induced growth inhibition. Cancer Res (2001) 1.36

Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors. Cancer (1992) 1.34

Hematolymphoid malignancies diagnosed at the time of radical prostatectomy. J Urol (1997) 1.34

Keratin immunoreactivity in the benign and neoplastic human prostate. Cancer Res (1985) 1.32

Nerve sparing radical prostatectomy: a different view. J Urol (1995) 1.32

The immunologic basis of recurrent bacteriuria: role of cervicovaginal antibody in enterobacterial colonization of the introital mucosa. Medicine (Baltimore) (1978) 1.29

RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole-3-ethanamine hydrochloride), a selective alpha 1A-adrenoceptor antagonist, displays low affinity for functional alpha 1-adrenoceptors in human prostate: implications for adrenoceptor classification. Mol Pharmacol (1996) 1.27

Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients. J Clin Endocrinol Metab (1993) 1.26

Prostate cancer is highly predictable: a prognostic equation based on all morphological variables in radical prostatectomy specimens. J Urol (2000) 1.25

MR imaging of the prostate gland: normal anatomy. AJR Am J Roentgenol (1987) 1.24

Positive surgical margins at radical prostatectomy: importance of the apical dissection. J Urol (1990) 1.21

Morphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol (1988) 1.20

Clinical and roentgenographic evaluation of endoscopic suspension of the vesical neck for urinary incontinence. Surg Gynecol Obstet (1975) 1.19

Histological and clinical findings in 896 consecutive prostates treated only with radical retropubic prostatectomy: epidemiologic significance of annual changes. J Urol (1998) 1.17

An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics. J Urol (2000) 1.16

Limitations of serum prostate specific antigen in predicting peripheral and transition zone cancer volumes as measured by correlation coefficients. J Urol (1996) 1.13

Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers. J Urol (2000) 1.13

Bacteriologic and hormonal observations of the urethra and vaginal vestibule in normal, premenopausal women. J Urol (1970) 1.12

Observations on the clinical use of nalidixic acid. Postgrad Med J (1971) 1.12

Molecular mass and carbohydrate structure of prostate specific antigen: studies for establishment of an international PSA standard. Prostate (1995) 1.11

Physiological variation of serum prostate specific antigen in the 4.0 to 10.0 ng./ml. range in male volunteers. J Urol (1996) 1.11

Distinction between intraductal carcinoma of the prostate (IDC-P), high-grade dysplasia (PIN), and invasive prostatic adenocarcinoma, using molecular markers of cancer progression. Prostate (2000) 1.10

Brain metastases from transitional cell carcinoma of the bladder. J Urol (1988) 1.10

Differential cytokeratin expression in normal, hyperplastic and malignant epithelial cells from human prostate. J Urol (1990) 1.10

Unsuspected adenocarcinoma of the prostate in patients undergoing cystoprostatectomy for other causes: incidence, histology and morphometric observations. J Urol (1989) 1.10

Hemorrhagic cystitis: a review. J Urol (1990) 1.09

Leiomyoma of bladder. Report of 2 cases and demonstration of ultrasonic appearance. Urology (1990) 1.07